All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99
Paper Submission

Why Us? >>
- Open Access
- Peer-reviewed
- Rapid publication
- Lifetime hosting
- Free indexing service
- Free promotion service
- More...
- Search engine friendly

Archive of "Therapeutic Advances in Neurological Disorders".

ISSN Print: 1756-2856

ISSN Online:

Website: https://www.ncbi.nlm.nih.gov/pmc/journals/1353/

Share:




Go

Preserved caudate function in young-onset patients with Parkinson’s disease: a dual-tracer PET imaging study

Chuan-tao Zuo,Feng-tao Liu,Jian Wang,Jian-jun Wu,Jing-jie Ge,Jue Zhao,Yilong Ma,Yu-jie Yang,Zhen-yang Liu

Embolic strokes of undetermined source: theoretical construct or useful clinical tool?

Andrei V. Alexandrov,Aristeidis H. Katsanos,Christos Krogias,George P. Paraskevas,Georgios Tsivgoulis,Konstantinos Tsioufis,Martin K？hrmann,Natan M. Bornstein,Peter D. Schellinger,Robin Lemmens,Valeria Caso

Autoimmune encephalitis associated with antibodies against the metabotropic glutamate receptor type 1: case report and review of the literature

Antonios Bayas,Corinna Bien,Markus Naumann,Monika Christ,Thomas Hagen,Torsten Müller

A new family with transportinopathy: increased clinical heterogeneity

Annalaura Torella,Corrado Angelini,Elena Pinzan,Maria Judit Molnar,Roberta Marozzo,Valentina Pegoraro,Vincenzo Nigro

The prevalence of intracranial stenosis in patients at low and moderate risk of stroke

Fei-xue Yue,Hong-xiu Chen,Li-juan Wang,Li-min Chen,Yi Yang,Ying-qi Xing

B cell depletion can be effective in multiple sclerosis but failed in a patient with advanced childhood cerebral X-linked adrenoleukodystrophy

Hendrik Rosewich,Jutta G？rtner,Stefan Nessler,Wolfgang Brück

Hereditary defect of cobalamin metabolism with adolescence onset resembling multiple sclerosis: 41-year follow up in two cases

Anna Lena Fisse,Janina Kneiphof,Jeremias Motte,Kalliopi Pitarokoili,Katrin Stra？burger-Krogias,Ludwig Kappos,Ralf Gold

Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis

Alberto Jáuregui,Daniel Ruiz,Francesc Carmona,Javier Pérez,Josep Gamez,Laura Romero,María Deu,María Salvadó,Miriam de Nadal,Olga Martínez,Pilar Su？é

Peripheral nerve disease secondary to systemic conditions in children

Jo M. Wilmshurst,Monique M. Ryan,Robert A. Ouvrier

Does statin increase the risk of intracerebral hemorrhage in stroke survivors? A meta-analysis and trial sequential analysis

Chen-Huan Chen,Chern-En Chiang,Chi Peng Chan,Chi-Jung Huang,Chih-Ping Chung,Hao-Min Cheng,Li-Yin Chien,Ru Jian Jonathan Teoh,Shih-Hsien Sung

Coenzyme Q10 supplementation reduces peripheral oxidative stress and inflammation in interferon-β1a-treated multiple sclerosis

Anna De Rosa,Antonio Capacchione,Antonio Carotenuto,Fortunata Carbone,Francesco Perna,Giuseppe Matarese,Marcello Moccia,Raffaele Palladino,Roberta Lanzillo,Roberto Albero,Teresa Micillo,Vincenzo Brescia Morra

Comparing longitudinal brain atrophy measurement techniques in a real-world multiple sclerosis clinical practice cohort: towards clinical integration?

A. Ribbens,C. Wang,H.N. Beadnall,M.H. Barnett,T. Billiet,W. Van Hecke

Human tissue kallikrein in the treatment of acute ischemic stroke

John J Volpi,Julie Chao,Michelle Alexander-Curtis,Philip M Bath,Rick Pauls,Todd A. Verdoorn

Evolution of clinical trials in multiple sclerosis

Amber Salter,Erik Wallstr？m,Gary Cutter,Olaf Stüve,Yinan Zhang

Immunology of stroke: from animal models to clinical trials

Antje Schmidt-Pogoda,Christoph Kleinschnitz,Jens Minnerup

Practice-changing developments in neuro-oncology: embracing heterogeneity

Michael Platten

Whole-brain magnetic resonance imaging of plaque burden and lenticulostriate arteries in patients with different types of stroke

Debiao Li,Fang Wu,Jiangang Duan,Kai Dong,Ling Zhang,Qi Yang,Qian Zhang,Xiaoxu Yang,Ye Wu,Zhaoyang Fan

Understanding the burden of refractory myasthenia gravis

Christiane Schneider-Gold,Nico Melzer,Tim Hagenacker,Tobias Ruck

Relative health-related quality of life after treatment of unruptured intracranial aneurysms: long-term outcomes and influencing factors

Benedikt Frank,Bernd-Otto Hütter,Christoph Kleinschnitz,Christoph M？nninghoff,Isabel Wanke,Karsten Wrede,Klaus Kaier,Marvin Darkwah Oppong,Michael Forsting,Oliver Müller,Paula Wittek,Philipp Dammann,Ramazan Jabbarli,Ulrich Sure

Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies

Daniela Piga,Eleonora Mauri,Francesca Magri,Giacomo P. Comi,Nereo Bresolin,Roberta Brusa,Sabrina Salani,Stefania Corti

Real-life outcomes of teriflunomide treatment in patients with relapsing multiple sclerosis: TAURUS-MS observational study

Andrew Chan,Boris A. Kallmann,Jennifer S. Kullmann,Klaus Tiel-Wilck,Ulrich Engelmann

The monoclonal antibody GNbAC1: targeting human endogenous retroviruses in multiple sclerosis

Martin Diebold,Tobias Derfuss

Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study

Andreas Hoepner,Andrei Miclea,Andrew Chan,Anke Salmen,Franca Wagner,Greta Zoehner,Lisa Schrewe,Maria Eleftheria Evangelopoulos,Nicole Kamber,Robert Hoepner,Roland Wiest

Outcome, efficacy and safety of endovascular thrombectomy in ischaemic stroke according to time to reperfusion: data from a multicentre registry

Amel Benali,Benjamin Friedrich,Christian Maegerlein,Jan Gralla,Joanna Schaafsma,Johannes Kaesmacher,Laurent Pierot,Manuel Requena,Marc Ribo,Marcel Arnold,Matthias Gawlitza,Mirjam Rachel Heldner,Pascal J. Mosimann,Pasquale Mordasini,Patrik Michel,Simon Jung,Steven D. Hajdu,Thomas Raphael Meinel,Urs Fischer,Vincent Costalat,Vitor Mendes Pereira

Are morphologic features of recent small subcortical infarcts related to specific etiologic aspects?

Christian Enzinger,Franz Fazekas,Joanna Wardlaw,Lena Nachbaur,Lukas Pirpamer,Sebastian Eppinger,Simon Fandler,Stefan Ropele,Thomas Gattringer

Risks and risk management in modern multiple sclerosis immunotherapeutic treatment

Heinz Wiendl,Joachim Havla,Luisa Klotz,Michael Barnett,Nicholas Schwab,Reinhard Hohlfeld,Stephen Reddel

Pulsed immune reconstitution therapy in multiple sclerosis

Finn Sellebjerg,Per Soelberg Sorensen

Radiomics: a novel feature extraction method for brain neuron degeneration disease using 18F-FDG PET imaging and its implementation for Alzheimer’s disease and mild cognitive impairment

Chuantao Zuo,Huiwei Zhang,Jiaying Lu,Jiehui Jiang,Juanjuan Jiang,Yupeng Li

Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis

Amgad Droby,Frauke Zipp,Muthuraman Muthuraman,Nabin Koirala,Ralf Deichmann,René-Maxime Gracien,Sergiu Groppa,Sven G. Meuth,Ulf Ziemann,Vinzenz Fleischer

Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson’s disease

Federica Rossetto,Francesca Baglio,Giuseppe Baselli,Laura Pelizzari,Maria Marcella Laganà,Mario Clerici,Mirco Galli,Niels Bergsland,Raffaello Nemni

An update on best practice of deep brain stimulation in Parkinson’s disease

Alfons Schnitzler,Christian J. Hartmann,Lars Wojtecki,Sabine Fliegen,Stefan J. Groiss

Advances in spinal cord imaging in multiple sclerosis

Ahmed Toosy,Antonio Ianniello,Carlo Pozzilli,Marcello Moccia,Olga Ciccarelli,Serena Ruggieri

Post-natalizumab disease reactivation in multiple sclerosis: systematic review and meta-analysis

Augusto A. Miravalle,Luca Prosperini,Pietro Iaffaldano,Revere P. Kinkel,Simone Fantaccini

Evaluation of a clinical score for predicting atrial fibrillation in cryptogenic stroke patients with insertable cardiac monitors: results from the CRYSTAL AF study

Calvin Kwong,Jodi L. Koehler,Michael H. Crawford,Paul D. Ziegler,Rod S. Passman,Susan X. Zhao

Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson’s disease: A pilot study

Antonella Conte,Antonella Giannantoni,Marilena Gubbiotti,Nicola Tambasco,Savino M. Di Stasi

Advances in cerebral amyloid angiopathy imaging

Bo-Chin Lee,Hon-Man Liu,Hsin-Hsi Tsai,Jiann-Shing Jeng,Li-Kai Tsai,Ruoh-Fang Yen,Sung-Chun Tang,Szu-Ju Chen

First in vivo visualization of the human subarachnoid space and brain cortex via optical coherence tomography

Belal Neyazi,Ibrahim Erol Sandalcioglu,Karl Hartmann,Klaus-Peter Stein

Metabolic lipid muscle disorders: biomarkers and treatment

Corrado Angelini,Daniela Tavian,Elena Pennisi,Sara Missaglia

Structural brain signature of cognitive decline in Parkinson’s disease: DTI-based evidence from the LANDSCAPE study

Alexander Storch,Daniela Berg,Elke Kalbe,Hans-Peter Müller,Inga Liepelt-Scarfone,Jan Kassubek,LANDSCAPE Consortium,Martin Gorges,Martin S. Kunz,Richard Dodel,Rüdiger Hilker-Roggendorf,Simon Baudrexel

Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age

Andrei Miclea,Andrew Chan,Anke Salmen,Christoph Friedli,Lara Diem,Maud Bagnoud,Myriam Briner,Robert Hoepner

Clinical trials in multiple sclerosis: potential future trial designs

Amber Salter,Benjamin M. Segal,Bernhard Hemmer,Gary Cutter,Hans-Peter Hartung,Navid Manouchehri,Olaf Stüve,Ralf Linker,Rehana Z. Hussain,Yinan Zhang

Severe rebound after cessation of fingolimod treated with ocrelizumab with coincidental transient aggravation: report of two cases

Stephan Schmidt,Thomas Schulten

Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment

Albert C. Ludolph,Andreas Hermann,Benedikt Winter,Claudia D. Wurster,Jan C. Koch,Jens Dreyhaupt,Kurt Wollinsky,Markus Otto,Paul Lingor,Petra Steinacker,René Günther,Simon Witzel,Susanne Petri,Tugrul Kocak,Zeljko Uzelac

Advances in imaging of brain abnormalities in neuromuscular disease

Corrado Angelini,Elena Pinzan

Multimodal MRI characteristics of the glioblastoma infiltration beyond contrast enhancement

Anouk van der Hoorn,Chao Li,Daniel M. Fountain,Jiun-Lin Yan,Natalie R. Boonzaier,Stephen J. Price,Timothy J. Larkin,Tomasz Matys

The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis

Anneke van der Walt,Daniel Merlo,David Darby,Helmut Butzkueven,Tomas Kalincik

Advances in brain imaging in multiple sclerosis

Ahmed T. Toosy,Olga Ciccarelli,Rosa Cortese,Sara Collorone

Neuroimaging markers of clinical progression in chronic inflammatory demyelinating polyradiculoneuropathy

Adnan Labedi,Anna Lena Fisse,Christoph Maier,Dietrich Sturm,Elena K. Enax-Krumova,Kalliopi Pitarokoili,Lynn Eitner,Martin Tegenthoff,Min-Suk Yoon,Nina Kumowski,Ralf Gold,Tineke Greiner,Tobias Schmidt-Wilcke

Non-invasive ventilation in amyotrophic lateral sclerosis

Albert C. Ludolph,Johannes Dorst

Therapeutic effect on experimental acute cerebral infarction is enhanced after nanoceria labeling of human umbilical cord mesenchymal stem cells

Gang Li,Lian Zuo,Mengruo Guo,Mengwei Chen,Qishuai Feng,Yingying Han,Yu Cheng,Zhongmin Liu

Go




©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705